Rights and permissions
About this article
Cite this article
Interferon-α-2b + ribavirin cost effective for mild hepatitis C. Pharmacoecon. Outcomes News 295, 9 (2001). https://doi.org/10.1007/BF03269059
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03269059